Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Delimobile in Q1 increased revenue from b2b-carsharing by 44%

4/17/25 DELI

MMK's sales in Q1 decreased by 11%

4/17/25 MAGN

Vyborg Shipyard reported for 3 months of 2025 by RAS

4/17/25 VSYD

Nekwalas will be given partial access to CFA through exchanges

4/17/25 SPBE

Bank Uralsib reported for 2024 according to IFRS

4/16/25 USBN

Alrosa will not pay final dividends for 2024

4/16/25 ALRS

Supl.biz reported for Q1 2025

4/16/25 OTCI

YuGK acquires prospecting licenses in the Severo-Yeniseisky district

4/16/25 UGLD

Supl.biz reported for 2024

4/16/25 OTCI

Polyus sold the Marokskoye geological exploration project

4/16/25 PLZL